Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it your doctor.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2016. The disclosure of these payments is required under the Physician Payment Sunshine Act, a provision of the 2010 Affordable Care Act.


About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk to your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: <a href='https://propub.li/participate-d4d'>propub.li/participate-d4d</a>

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many healthcare professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/77110
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to <strong>not</strong> be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/77110
If you spot an error, please let us know at [email protected]

STEPHEN STAHL

Listed Specialty:
1930 PALOMAR POINT WAY, SUITE 103, CARLSBAD, CA, 92008-5579

Payments: At a Glance

294

payments

$5,248,170

payment total

21

companies paid this doctor

Types of Payments

Category Payments Payment Value
Promotional Speaking/Other
51 $4.53M
Consulting
53 $620K
Travel and Lodging
100 $66,798
Honoraria
5 $16,733
Education
13 $10,877
Food and Beverage
72 $4,662

Drugs & Devices

Totals listed below account for all payments from August 2013 to December 2016 that mention this product. If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments
BRINTELLIX

drug

$1.79M
TRINTELLIX

drug

$619K
LATUDA

drug

$349K
ABILIFY

drug

$140K
VRAYLAR

drug

$48,458
NUEDEXTA

drug

$29,429
ARIPIPRAZOLE

drug

$16,059
BREXPIPRAZOLE

drug

$13,754
FANAPT

drug

$6,543
KUVAN TABLETS

drug

$4,031
CLOZAPINE

drug

$1,800
CONTRAVE

drug

$1,625
LAZANDA

drug

$1,500
SAPHRIS

drug

$500
XYREM

drug

$440
ABILIFY MAINTENA

drug

$85
REXULTI

drug

$39
VERSACLOZ

drug

$28
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

Payment Details

When How Much Related To What For From Third Party Payee
Feb 5, 2014 $1,303,270

No Listed Product Promotional Speaking/Other

Details: Indirect Payment to a 3rd party, physician owned entity as part of fee for service engagement. This is not a direct payment to the physician as part of a direct business relationship.

Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
Sep 24, 2013 $729,970

No Listed Product Promotional Speaking/Other

Details: Indirect Payment to a 3rd party, physician owned entity as part of fee for service engagement. This is not a direct payment to the physician as part of a direct business relationship.

Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
Oct 1, 2013 $637,471

Brintellix Promotional Speaking/Other

Details: Indirect Payment to a 3rd party, physician owned entity as part of fee for service engagement. This is not a direct payment to the physician as part of a direct business relationship.

Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
Oct 2, 2013 $511,182

Brintellix Promotional Speaking/Other

Details: Indirect Payment to a 3rd party, physician owned entity as part of fee for service engagement. This is not a direct payment to the physician as part of a direct business relationship.

Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
Mar 25, 2015 $366,190

Brintellix Promotional Speaking/Other

Details: Indirect Payment to a 3rd party, physician owned entity as part of fee for service engagement. This is not a direct payment to the physician as part of a direct business relationship.

Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
Sep 22, 2014 $139,460

ABILIFY Consulting Otsuka America Pharmaceutical, Inc.
Mar 27, 2015 $100,823

Brintellix Promotional Speaking/Other

Details: Indirect Payment to a 3rd party, physician owned entity as part of fee for service engagement. This is not a direct payment to the physician as part of a direct business relationship.

Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
Aug 7, 2013 $84,976

No Listed Product Promotional Speaking/Other

Details: Indirect Payment to a 3rd party, physician owned entity as part of fee for service engagement. This is not a direct payment to the physician as part of a direct business relationship.

Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
Aug 2, 2016 $82,035

Trintellix Promotional Speaking/Other

Details: Indirect Payment to a 3rd party, physician owned entity as part of fee for service engagement. This is not a direct payment to the physician as part of a direct business relationship.

Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
May 17, 2016 $72,876

Trintellix Promotional Speaking/Other

Details: Indirect Payment to a 3rd party, physician owned entity as part of fee for service engagement. This is not a direct payment to the physician as part of a direct business relationship.

Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
Dec 31, 2015 $67,543

Latuda Consulting Sunovion Pharmaceuticals Inc.
Jun 6, 2016 $62,855

Trintellix Promotional Speaking/Other

Details: Indirect Payment to a 3rd party, physician owned entity as part of fee for service engagement. This is not a direct payment to the physician as part of a direct business relationship.

Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
May 13, 2016 $60,094

Trintellix Promotional Speaking/Other Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
Jun 30, 2016 $56,670

Trintellix Promotional Speaking/Other

Details: Indirect Payment to a 3rd party, physician owned entity as part of fee for service engagement. This is not a direct payment to the physician as part of a direct business relationship.

Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
Aug 2, 2016 $56,640

Trintellix Promotional Speaking/Other

Details: Indirect Payment to a 3rd party, physician owned entity as part of fee for service engagement. This is not a direct payment to the physician as part of a direct business relationship.

Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
Apr 1, 2016 $55,316

Trintellix Promotional Speaking/Other Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
Mar 27, 2015 $50,933

Brintellix Promotional Speaking/Other

Details: Indirect Payment to a 3rd party, physician owned entity as part of fee for service engagement. This is not a direct payment to the physician as part of a direct business relationship.

Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
Jul 31, 2015 $35,712

Latuda Consulting Sunovion Pharmaceuticals Inc.
Dec 7, 2015 $35,406

Brintellix Promotional Speaking/Other

Details: Indirect Payment to a 3rd party, physician owned entity as part of fee for service engagement. This is not a direct payment to the physician as part of a direct business relationship.

Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
Dec 9, 2016 $31,657

Trintellix Promotional Speaking/Other

Details: Indirect Payment to a 3rd party, physician owned entity as part of fee for service engagement. This is not a direct payment to the physician as part of a direct business relationship.

Takeda Pharmaceuticals U.S.A., Inc. Arbor Scientia
Sep 12, 2016 $28,600

Trintellix Promotional Speaking/Other Takeda Pharmaceuticals U.S.A., Inc.

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/77110

Note: We have made some effort to normalize the data and eliminate duplicates, but data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].